Section Arrow
IXHL.NASDAQ
- Incannex Healthcare
(Financial Status)
Quotes are at least 15-min delayed:2025/11/07 18:37 EST
After Hours
Last
 0.348
-0.0004 (-0.11%)
Bid
0.348
Ask
0.3496
High 0.3537 
Low 0.3473 
Volume 272031 
Regular Hours
Last
 0.3484
-0.0157 (-4.31%)
Day High 
0.3544 
Prev. Close
0.3641 
1-M High
0.464 
Volume 
9.27M 
Bid
0.349
Ask
0.3493
Day Low
0.343 
Open
0.3516 
1-M Low
0.3326 
Market Cap 
126.60M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.36 
20-SMA 0.37 
50-SMA 0.47 
52-W High 3.1199 
52-W Low 0.08 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.35/-1.56
Enterprise Value
126.67M
Balance Sheet
Book Value Per Share
0.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
86.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.24+0.03+2.48%-- 
After Hours 1.27 +0.03 +2.42%
ORGOOrganogenesis Holdings5.63+1.74+44.73%60.5PE
After Hours 5.6989 +0.0689 +1.22%
CGCCanopy Growth Corp1.17+0.08+7.34%-- 
After Hours 1.17 0 0.00%
HIMSHims & Hers Health41.03-0.49-1.18%77.62PE
After Hours 41.2282 +0.1982 +0.48%
TEVATeva Pharmaceutical Industries Limited23.97-0.49-2.00%39.98PE
After Hours 24.1 +0.13 +0.54%
Quotes are at least 15-min delayed:2025/11/07 18:37 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.